Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Midday trading on March 10 saw significant price swings in several stocks, including Rivian (RIVN), Hims & Hers (HIMS), BioNTech (BNTX), Vertex Pharmaceuticals (VRTX), and others. The moves were driven by earnings updates, product announcements, and broader market volatility.
The rally follows a week of mixed earnings and a shift in investor sentiment toward growth and biotech. Recent macro data and Fed signals have heightened risk appetite, prompting traders to seek catalysts in individual names.
Rivian's 12% jump after a stronger-than-expected Q4 vehicle delivery outlook signals renewed confidence in EV demand, but the stock remains volatile due to supply chain concerns. Hims & Hers' 8% rise reflects a new partnership with a major telehealth platform, suggesting a broader shift toward integrated digital health services. BioNTech’s 6% climb following a positive Phase III trial update for its COVID-19 booster underscores the biotech sector’s continued focus on pandemic‑related products, while Vertex’s 5% gain on a promising gene‑editing pipeline indicates investor appetite for next‑generation therapies.
Retail investors in the EV and biotech space will watch these stocks for further momentum, while institutional traders may adjust exposure based on earnings guidance. Market makers should monitor volatility spikes and potential support levels around key technical thresholds.
- Rivian's delivery outlook fuels renewed EV demand optimism.
- Hims & Hers partnership signals growth in digital health.
- BioNTech and Vertex gains highlight biotech’s pandemic and gene‑editing focus.